PODESTA GROUP, INC. for AMGEN
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 19, 2010 | $90,000 | Replaced |
| 4th Quarter - Amendment (this page) | Nov 3, 2010 | $90,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Follow-on biologics H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 3200 America's Affordable Health Choices Act of 2009 H.R. 3962 Affordable Health Care for America Act H.R. 3590 Patient Protection & Affordable Care Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELE BAIERLEIN New | — |
| TEAL BAKER | Executive Assistant Rep. Brian Baird |
| SHARON COHEN New | — |
| JAIME R HARRISON New | Executive Director, House Democratic Caucus |
| ANDREW KAUDERS New | Agriculture Dept., WH Climate Change, EPA |
| ANTHONY PODESTA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.